MCI in the News

Curcumin Selected as Cognition Supplement of the Year: 2021

February 1, 2021

Curcumin, the best-known component of the popular spice turmeric, has been selected as the “Cognition Supplement of the Year: 2021,” announces Leslie Norins, MD, PhD, FIDSA, founder and CEO of MCI911.com.

“Medical journals reveal many positive reports of this natural food supplement aiding cognition maintenance and even improvement,” says Dr. Norins.

He believes these beneficial properties can be especially relevant to senior citizens coping with MCI, a serious memory disorder, which sometimes can be a harbinger of Alzheimer’s disease.

“As yet, there is no licensed prescription drug available to cure MCI, and that’s why it’s important to look into every well-tolerated substance that might alleviate or halt the memory losses of this condition,” says Dr. Norins.

Curcumin is available OTC in health food departments and is relatively inexpensive.  The world’s leading producer and exporter is India. “Before taking this or any supplement, check with your physician,” advises Dr. Norins.

To explain the reasons for curcumin’s designation, MCI911.com is offering free of charge its downloadable Special Report,

Curcumin: An Often-Overlooked Supplement That May Assist Cognition.” There is no charge or obligation.

Unfortunately, most research on Alzheimer’s disease focuses on the later stages of the affliction, which include marked memory loss, and invariably, a slow death, Dr. Norins says. “So, why not try relatively-safe substances that may help bolster cognition?” Dr. Norins freely admits the mechanism whereby curcumin can help is not yet fully understood, but there are several theories.

MCI911.com overall advocates an activist posture, challenging MCI and failing memories with adjustments in supplements, diets, lifestyle, exercise, and brain training. Dr. Norins advises, “Do not sit idle, wringing your hands. Though conventional medicine has little to offer at this time, there is no reason not to try other things (if your physician approves) that have been reported to sometimes ‘work.’”

He labels these actions “counterattack.” Their rationale is presented in a White Paper and a video.